Salute e Benessere
Lusochimica S.p.A. (Menarini Group) awarded by the European Commission with the 'STEP Seal' award and EU funding for the SmartNEBI project, which makes the synthesis of nebivolol greener and more sustainable
The project is managed by HaDEA, an executive agency of the European Commission, and funded under EU4Health, the EU funding programme designed, amongst other objectives, to tackle cross-border health challenges through high-quality, innovative projects in the health sector. This endorsement highlights SmartNEBI's strategic contribution to the objectives of the and recognizes its value for Europe's technological and industrial development.
The innovation behind SmartNEBI lies in the synergistic integration of —a process that utilizes enzymes as biological catalysts to drive chemical transformations in a selective, efficient, and environmentally friendly manner—and , which enables operations to be carried out with greater efficiency and under safer conditions, with improved heat and mass transfer. This combination allows for a more productive, scalable, and sustainable synthesis of nebivolol, resulting in reduced environmental impact, particularly in terms of energy consumption.
said Roberto Falorni , General Manager of Lusochimica S.p.A.
Lusochimica S.p.A. is an Italian company within the Menarini Group engaged in the production and synthesis of active pharmaceutical ingredients (APIs) and the development of scalable manufacturing processes. Headquartered in Lomagna (LC), it operates three manufacturing sites in Lomagna, Pisa , and Casaletto Lodigiano (LO). All production processes strictly comply with international cGMP standards.
www.lusochimica.it
The Menarini Group is a pharmaceutical and diagnostics company headquartered in
Florence , operating in 140 countries worldwide. With consolidated revenues of €4.603 billion and more than 17,000 employees, the company operates 9 R&D centers and is active in major therapeutic areas including cardiology, oncology, gastroenterology, pulmonology, infectious diseases, diabetology, inflammation, and analgesia. Pharmaceutical production is carried out in 18 manufacturing sites located in
Italy and abroad, producing and distributing over 609 million packs annually across five continents. Menarini's manufacturing excellence consistently contributes to global patient health with the highest quality standards.
www.menarini.com
Logo: https://mma.prnewswire.com/media/2778446/LUSOCHIMICA_Logo.jpg
Logo: https://mma.prnewswire.com/media/2778447/Cofunded_EU_Logo.jpg